Binding of peptides from the N-terminal region of α-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays

Clinical Immunology and Immunopathology

Volumn 79, Issue 3, 1996, Pages 288-293

  Johansen, Bente H ^a   Gjertsen, Henrik A ^a   Vartdal, Frode ^a   Buus, Søren ^b   Thorsby, Erik ^a   Lundin, Knut E A ^a   Sollid, Ludvig M ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLIADIN; HLA DQ ANTIGEN; HLA DR ANTIGEN; SYNTHETIC PEPTIDE;

ARTICLE; CELIAC DISEASE; CELL CLONE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029940377     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0081     Document Type: Article

References (23)

1. Trier, J. S., Celiac sprue. N. Engl. J. Med. 325, 1709-1719, 1991.
2. Marsh, M. N., Gluten, major histocompatibility complex, and the small intestine. Gastroenterology 102, 330-354, 1992.
3. Brandtzaeg, P., Immunological basis for celiac disease, inflammatory bowel disease and type B chronic gastritis. Curr. Opin. Gastroenterol. 7, 450-462, 1991.
4. Sollid, L. M., Markussen, G., Ek, J., Gjerde, H., Vartdal, F., and Thorsby, E., Evidence for a primary associaion of celiac disease to a particular HLA-DQ α/β heterodimer. J. Exp. Med. 169, 345-350, 1989.
5. Kagnoff, M. F., Harwood, J. I., Bugawan, T. L., and Erlich, H. A., Structural analysis of the HLA-DR, -DQ and -DP alleles on the celiac disease-associated HLA-DR3 (DRw17) haplotype. Proc. Natl. Acad. Sci. USA 86, 6274-6278, 1989.
6. Sollid, L. M., and Thorsby, E., HLA susceptibility genes in celiac disease: Genetic mapping and role in pathogenesis. Gastroenterology 105, 910-922, 1993.
7. Lundin, K. E. A., Scott, H., Hansen, T., Paulsen, G., Halstensen, T. S., Fausa, O., Thorsby, E., and Sollid, L. M., Gliadin-specific, HLA-DQ(α1*0501, β1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J. Exp. Med. 178, 187-196, 1993.
8. Wieser, H., Belitz, H. D., and Ashkenazi, A., Amino-acid sequence of the coeliac active gliadin peptide B3142. Z. Lebensm.-Unters. Forsch. 179, 371-376, 1984.
9. de Ritis, G., Auricchio, S., Jones, H. W., Lew, E. J. L., Bernardin, J. E., and Kasarda, D. D., In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. Gastroenterology 94, 41-49, 1988.
10. Sturgess, R., Day, P., Ellis, H. J., Lundin, K. E. A., Gjertsen, H. A., Kontakou, M., and Ciclitira, P. J., Wheat peptide challenge in coeliac disease. Lancet 343, 758-761, 1994.
11. Franco, A., Appella, E., Kagnoff, M. F., Chowers, Y., Sakaguchi, K., Grey, H. M., and Sette, A., Peripheral T cell responce to A-gliadin in celiac disease: Differential processing and presentation capacities of Epstein-Barr-transformed B cells and fibroblasts. Clin. Immunol. Immunopathol. 71, 75-81, 1994.
12. Gjertsen, H. A., Lundin, K. E. A., Sollid, L. M., Eriksen, J. A., and Thorsby, E., T cells recognize a peptide derived from α-gliadin presented by the celiac disease-associated HLA-DQ(α1*0501, β1*0201) heterodimer. Hum. Immunol. 39, 243-252, 1994.
13. Johansen, B. H., Buus, S., Vartdal, F., Viken, H., Eriksen, J. A., Thorsby, E., and Sollid, L. M., Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease associated HLA-DQ(α1*0501, β1*0201) molecule. Int. Immunol. 6, 453-461, 1994.
14. Buus, S., Sette, A., Colon, S. M., Jenis, D. M., and Grey, H. M., Isolation an characterization of antigen-la complexes involved in T cell recognition. Cell 47, 1071-1077, 1986.
15. Gorga, J. C., Horejsi, V., Johnson, D. R., Raghupathy, R., and Strominger, J. L., Purification and charaterization of class II histocompatiblity antigens from a homozygous human B cell line. J. Biol. Chem. 262, 16087-16094, 1987.
16. Viken, H. D., Paulsen, G., Sollid, L. M., Lundin, K. E. A., Tjønnfjord, G. E., Thorsby, E., and Gaudernack, G., Characterization of an HLA-DQ2-specific monoclonal antibody: Influence of amino acid substitutions in DQβ1*0202. Hum. Immunol. 42, 319-322, 1995.
17. k cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb. Eur. J. Immunol. 13, 106-111, 1983.
18. Schneider, C., Newman, R. A., Sutherland, D. R., Asser, U., and Greaves, M. F., A one-step purifiaction of membrane proteins using a high efficiency immunomatrix. J. Biol. Chem. 257, 10766-10769, 1982.
19. 131I-labelled human growth hormone of high specific radioactivity. Biochem. J. 89, 114-123, 1963.
20. Buus, S., Stryhn, A., Winter, K., Kirkby, N., and Pedersen, L. Ø., Receptor-ligand interactions measured by an improved spun column chromatography technique: A high efficiency and high throughput size separation method. Biochim. Biophys. Acta 1243, 453-460, 1995.
21. Fluge, Ø., Sletten, K., Fluge, G., Aksnes, L., and Elsayed, S., In vitro toxisity of purified gluten peptides tested by organ culture. J. Pediatr. Gastroent. Nutr. 18, 186-192, 1994.
22. Chowers, Y., Theofilopoulus, A., deGrandpre, L., Balderas, R., Marsh, M. N., Crowe, P., and Kagnoff, M. F., Rectal gluten challenge of celiac disease patients is associated with secretion of proinflammatory cytokines and a polyclonal T cell response. Clin. Immunol. Immunopathol. 76, 124, 1995. [Abstract 730]
23. Maiuri, L., Picarelli, A., Londei, M., Boirivant, M., Coletta, S., Mazzilli, M. C., De Vincenzi, M., and Auricchio, S., Definition of the initial immunological modifications upon gliadin challenge in the small intestine of celiacs. Clin. Immunol. Immunopathol. 76, 124, 1995. [Abstract 730]